138 related articles for article (PubMed ID: 2022031)
21. Effects of endothelin on renal function in newborn rabbits.
Semama DS; Thonney M; Guignard JP; Gouyon JB
Pediatr Res; 1993 Aug; 34(2):120-3. PubMed ID: 8233710
[TBL] [Abstract][Full Text] [Related]
22. Effects of endothelin-1 on renal function in humans: implications for physiology and pathophysiology.
Rabelink TJ; Kaasjager KA; Boer P; Stroes EG; Braam B; Koomans HA
Kidney Int; 1994 Aug; 46(2):376-81. PubMed ID: 7967349
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular, renal, and endocrine responses to intravenous endothelin in conscious dogs.
Goetz KL; Wang BC; Madwed JB; Zhu JL; Leadley RJ
Am J Physiol; 1988 Dec; 255(6 Pt 2):R1064-8. PubMed ID: 3059828
[TBL] [Abstract][Full Text] [Related]
24. Haemodynamic effects of human alpha-calcitonin gene-related peptide following administration of endothelin-1 or NG-nitro-L-arginine methyl ester in conscious rats.
Gardiner SM; Compton AM; Kemp PA; Bennett T; Foulkes R; Hughes B
Br J Pharmacol; 1991 May; 103(1):1256-62. PubMed ID: 1878760
[TBL] [Abstract][Full Text] [Related]
25. Evidence for metalloprotease involvement in the in vivo effects of big endothelin 1.
Pollock DM; Opgenorth TJ
Am J Physiol; 1991 Jul; 261(1 Pt 2):R257-63. PubMed ID: 1650147
[TBL] [Abstract][Full Text] [Related]
26. Renal-specific actions of angiotensin II receptor antagonism in the anesthetized dog.
Chan DP; Sandok EK; Aarhus LL; Heublein DM; Burnett JC
Am J Hypertens; 1992 Jun; 5(6 Pt 1):354-60. PubMed ID: 1524759
[TBL] [Abstract][Full Text] [Related]
27. Effects of endothelin on adrenergic neurotransmission in the dog kidney.
Takagi H; Hisa H; Satoh S
Eur J Pharmacol; 1991 Oct; 203(2):291-4. PubMed ID: 1666048
[TBL] [Abstract][Full Text] [Related]
28. Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism.
Wada A; Tsutamoto T; Ohnishi M; Sawaki M; Fukai D; Maeda Y; Kinoshita M
Circulation; 1999 Feb; 99(4):570-7. PubMed ID: 9927406
[TBL] [Abstract][Full Text] [Related]
29. Exogenous endothelin-1 causes renal vasodilation in the fetal lamb.
Bogaert GA; Kogan BA; Mevorach RA; Wong J; Gluckman GR; Fineman JR; Heymann MA
J Urol; 1996 Aug; 156(2 Pt 2):847-53. PubMed ID: 8683799
[TBL] [Abstract][Full Text] [Related]
30. Control of renal function during intrarenal infusion of endothelin.
Stacy DL; Scott JW; Granger JP
Am J Physiol; 1990 May; 258(5 Pt 2):F1232-6. PubMed ID: 2186632
[TBL] [Abstract][Full Text] [Related]
31. Effect of endothelin on total and regional coronary resistance and on myocardial contractility.
Domenech R; Macho P; González R; Huidobro-Toro JP
Eur J Pharmacol; 1991 Jan; 192(3):409-16. PubMed ID: 2055239
[TBL] [Abstract][Full Text] [Related]
32. Plasma endothelin concentrations in humans with end-stage heart failure and after heart transplantation.
Lerman A; Kubo SH; Tschumperlin LK; Burnett JC
J Am Coll Cardiol; 1992 Oct; 20(4):849-53. PubMed ID: 1527295
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the role of endothelin, vasopressin and angiotensin in arterial pressure regulation during sevoflurane anaesthesia in dogs.
Picker O; Schwarte LA; Roth HJ; Greve J; Scheeren TW
Br J Anaesth; 2004 Jan; 92(1):102-8. PubMed ID: 14665561
[TBL] [Abstract][Full Text] [Related]
34. Effects of endothelin-1 and sarafotoxin S6b on regional hemodynamics in the conscious dog.
Leadley RJ; Zhu JL; Goetz KL
Am J Physiol; 1991 Jun; 260(6 Pt 2):R1210-7. PubMed ID: 2058748
[TBL] [Abstract][Full Text] [Related]
35. Evidence from receptor antagonists of an important role for ETB receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney.
Wellings RP; Corder R; Warner TD; Cristol JP; Thiemermann C; Vane JR
Br J Pharmacol; 1994 Feb; 111(2):515-20. PubMed ID: 8004396
[TBL] [Abstract][Full Text] [Related]
36. Effects of endothelin on systemic and renal haemodynamics and neuroendocrine hormones in conscious dogs.
Nakamoto H; Suzuki H; Murakami M; Kageyama Y; Ohishi A; Fukuda K; Hori S; Saruta T
Clin Sci (Lond); 1989 Nov; 77(5):567-72. PubMed ID: 2555107
[TBL] [Abstract][Full Text] [Related]
37. Endothelin-specific antibodies decrease blood pressure and increase glomerular filtration rate and renal plasma flow in spontaneously hypertensive rats.
Ohno A; Naruse M; Kato S; Hosaka M; Naruse K; Demura H; Sugino N
J Hypertens; 1992 Aug; 10(8):781-5. PubMed ID: 1325510
[TBL] [Abstract][Full Text] [Related]
38. Role of endogenous endothelin-1 in experimental renal hypertension in dogs.
Donckier J; Stoleru L; Hayashida W; Van Mechelen H; Selvais P; Galanti L; Clozel JP; Ketelslegers JM; Pouleur H
Circulation; 1995 Jul; 92(1):106-13. PubMed ID: 7788903
[TBL] [Abstract][Full Text] [Related]
39. [Endothelin, a peptidic vasoconstrictor].
Dousset B; Jacob C
Presse Med; 1992 Apr; 21(14):665-9. PubMed ID: 1317961
[TBL] [Abstract][Full Text] [Related]
40. BNP: pathophysiological and potential therapeutic roles in acute congestive heart failure.
Grantham JA; Borgeson DD; Burnett JC
Am J Physiol; 1997 Apr; 272(4 Pt 2):R1077-83. PubMed ID: 9140004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]